Close Menu

NEW YORK (GenomeWeb) - Exiqon today reported a 24 percent increase year over year in its second quarter revenues.

For the three months ended June 30, Exiqon's total revenues increased to DKK 38 million ($5.8 million) from DKK 30.7 million in the prior-year period.

"We continue to deliver high growth, increased innovation, and profitability," Exiqon CEO Lars Kongsbak said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.